GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...
The peptides that are under the GLP-1 class that everyone touts as the weight loss miracle are not new. They've been around ...
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.